Dell Technologies Inc vs Herbalife Nutrition Ltd — how do they compare? Dell Technologies Inc trades at $411.5 (market cap $295.64B), while Herbalife Nutrition Ltd trades at $12.58 (market cap $1.27B). The key difference: Dell Technologies Inc is far larger — about 232.8× Herbalife Nutrition Ltd's market cap, and Dell Technologies Inc pays a 0.55% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| DELL | HLF | |
|---|---|---|
Market Cap | $295.64B | $1.27B |
Sector | Technology | Consumer Staples |
52-Week High | $466.02 | $19.96 |
52-Week Low | $111.10 | $7.75 |
Enterprise Value | $315.22B | $3.00B |
Dividend Yield | 0.55% | — |
Signals from Pluang's Aura AI — not financial advice
Dell Technologies (DELL) trades at $426.9, down 1.87% on the day, but remains in a bullish technical trend with strong fundamental momentum. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.86 significantly exceeding the $2.96 forecast. Revenue for 2025 reached $95.57 billion, with a net income margin improving to 4.8%. Analyst sentiment is overwhelmingly positive, with a consensus price target of $487.06, suggesting substantial upside from current levels.
The outlook for DELL is favorable, driven by its position in AI infrastructure and partnerships with leaders like Nvidia. Key opportunities include projected revenue growth to $134 billion in 2026 and expanding profitability. Risks involve competitive pressures in the PC market, memory chip supply constraints, and macroeconomic sensitivity. The stock presents a compelling growth story, but investors should weigh execution risks against the strong analyst conviction.
Herbalife (HLF) trades at $13.10, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 77.78% gross margin and attractive valuation metrics including a P/E of 5.75 and P/S of 0.27. Recent Q1 2026 earnings beat expectations with EPS of $0.64 versus $0.607 expected, while the company completed a $1.45 billion debt refinancing in April 2026 to strengthen its balance sheet.
The outlook remains positive with analyst consensus favoring Buy ratings (57.69%) and improving debt-to-asset ratios from 82.84% in 2024 to 71.67% in 2025. Key risks include high leverage, competitive pressures in the nutrition space, and regional market volatility. The stock offers value appeal given low multiples and recent strategic initiatives to expand digital health offerings.
Trailing returns across standard periods
Latest headlines on both assets
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →